Cynthia Kanagaratham, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Food Hypersensitivity | 6 | 2022 | 622 | 1.640 |
Why?
|
| Immunoglobulin E | 9 | 2023 | 1460 | 1.590 |
Why?
|
| Mast Cells | 6 | 2023 | 1544 | 1.260 |
Why?
|
| Receptors, IgE | 4 | 2023 | 389 | 1.130 |
Why?
|
| Allergens | 11 | 2022 | 1314 | 1.130 |
Why?
|
| Hypersensitivity | 4 | 2017 | 1093 | 1.070 |
Why?
|
| Chromosomes, Mammalian | 2 | 2017 | 151 | 1.050 |
Why?
|
| Basophils | 2 | 2022 | 389 | 0.840 |
Why?
|
| Fenretinide | 2 | 2020 | 12 | 0.700 |
Why?
|
| Omeprazole | 1 | 2020 | 112 | 0.690 |
Why?
|
| Asthma | 9 | 2020 | 5955 | 0.600 |
Why?
|
| Receptors, Fc | 1 | 2020 | 540 | 0.580 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2018 | 274 | 0.550 |
Why?
|
| Anaphylaxis | 1 | 2023 | 746 | 0.540 |
Why?
|
| Food | 2 | 2018 | 769 | 0.480 |
Why?
|
| Immunoglobulin G | 3 | 2023 | 4554 | 0.450 |
Why?
|
| Cell Degranulation | 2 | 2023 | 287 | 0.380 |
Why?
|
| Receptors, IgG | 3 | 2023 | 582 | 0.360 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 1887 | 0.340 |
Why?
|
| Respiratory Tract Diseases | 1 | 2014 | 722 | 0.330 |
Why?
|
| Toll-Like Receptors | 2 | 2014 | 592 | 0.320 |
Why?
|
| Sex Characteristics | 1 | 2018 | 2585 | 0.300 |
Why?
|
| Disease Models, Animal | 6 | 2020 | 18006 | 0.290 |
Why?
|
| Ovalbumin | 3 | 2020 | 719 | 0.280 |
Why?
|
| Quantitative Trait Loci | 1 | 2014 | 2015 | 0.280 |
Why?
|
| Chromosome Mapping | 1 | 2014 | 4742 | 0.270 |
Why?
|
| Desensitization, Immunologic | 2 | 2020 | 483 | 0.270 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 1788 | 0.250 |
Why?
|
| Th2 Cells | 2 | 2020 | 1049 | 0.250 |
Why?
|
| Tryptophan | 3 | 2015 | 478 | 0.230 |
Why?
|
| Gene Expression Profiling | 3 | 2014 | 9410 | 0.220 |
Why?
|
| Animals | 17 | 2023 | 168561 | 0.190 |
Why?
|
| Membrane Proteins | 1 | 2018 | 7873 | 0.190 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 4328 | 0.180 |
Why?
|
| T-Lymphocytes, Regulatory | 4 | 2020 | 2986 | 0.180 |
Why?
|
| Pyroglyphidae | 1 | 2020 | 87 | 0.170 |
Why?
|
| Mice | 11 | 2023 | 81045 | 0.170 |
Why?
|
| Lung | 1 | 2018 | 9826 | 0.170 |
Why?
|
| Genetic Variation | 1 | 2014 | 6540 | 0.170 |
Why?
|
| Fecal Impaction | 1 | 2018 | 34 | 0.170 |
Why?
|
| B-Cell Activating Factor | 1 | 2018 | 119 | 0.160 |
Why?
|
| Inflammation Mediators | 2 | 2020 | 1889 | 0.160 |
Why?
|
| Ascaris suum | 1 | 2018 | 11 | 0.160 |
Why?
|
| Methacholine Chloride | 1 | 2018 | 233 | 0.160 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2018 | 90 | 0.150 |
Why?
|
| Helminth Proteins | 1 | 2018 | 171 | 0.150 |
Why?
|
| Phenotype | 3 | 2020 | 16331 | 0.150 |
Why?
|
| Sphingolipids | 1 | 2018 | 159 | 0.140 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2018 | 172 | 0.140 |
Why?
|
| Arachidonic Acid | 2 | 2014 | 434 | 0.140 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2018 | 163 | 0.140 |
Why?
|
| Cation Transport Proteins | 1 | 2018 | 327 | 0.130 |
Why?
|
| src-Family Kinases | 1 | 2018 | 551 | 0.130 |
Why?
|
| Mice, Knockout | 4 | 2018 | 14554 | 0.130 |
Why?
|
| Mice, Congenic | 1 | 2014 | 99 | 0.120 |
Why?
|
| Pseudomonas Infections | 1 | 2018 | 608 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 2 | 2018 | 5867 | 0.120 |
Why?
|
| Tyrosine | 1 | 2018 | 1460 | 0.120 |
Why?
|
| Immunization | 1 | 2018 | 1255 | 0.120 |
Why?
|
| Luciferases, Renilla | 1 | 2013 | 22 | 0.110 |
Why?
|
| Luciferases, Firefly | 1 | 2013 | 46 | 0.110 |
Why?
|
| Organ Specificity | 1 | 2018 | 2003 | 0.110 |
Why?
|
| Chloroquine | 1 | 2014 | 280 | 0.110 |
Why?
|
| CD40 Ligand | 1 | 2014 | 526 | 0.110 |
Why?
|
| Bronchial Hyperreactivity | 2 | 2011 | 319 | 0.110 |
Why?
|
| Esophagus | 1 | 2018 | 1017 | 0.110 |
Why?
|
| Recombination, Genetic | 1 | 2017 | 1586 | 0.110 |
Why?
|
| Gene Deletion | 2 | 2018 | 2751 | 0.110 |
Why?
|
| HIV Infections | 5 | 2017 | 16678 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 4 | 2018 | 21821 | 0.100 |
Why?
|
| Secretory Leukocyte Peptidase Inhibitor | 1 | 2011 | 23 | 0.100 |
Why?
|
| Respiratory Tract Infections | 1 | 2018 | 959 | 0.100 |
Why?
|
| Docosahexaenoic Acids | 2 | 2014 | 875 | 0.100 |
Why?
|
| Genetic Markers | 1 | 2017 | 2633 | 0.100 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 1525 | 0.090 |
Why?
|
| HSC70 Heat-Shock Proteins | 1 | 2010 | 52 | 0.090 |
Why?
|
| Macrophages | 2 | 2018 | 5655 | 0.090 |
Why?
|
| Species Specificity | 1 | 2014 | 2479 | 0.090 |
Why?
|
| Cystic Fibrosis | 1 | 2018 | 1178 | 0.090 |
Why?
|
| Patents as Topic | 1 | 2011 | 103 | 0.090 |
Why?
|
| Cell Nucleolus | 1 | 2010 | 166 | 0.090 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2014 | 1372 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 6382 | 0.080 |
Why?
|
| Cytokines | 2 | 2022 | 7317 | 0.080 |
Why?
|
| Genes, Reporter | 1 | 2013 | 1547 | 0.080 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 2867 | 0.080 |
Why?
|
| Signal Transduction | 3 | 2020 | 23387 | 0.080 |
Why?
|
| Lipopolysaccharides | 1 | 2014 | 2211 | 0.070 |
Why?
|
| Th17 Cells | 1 | 2013 | 765 | 0.070 |
Why?
|
| Cloning, Molecular | 1 | 2013 | 4322 | 0.070 |
Why?
|
| Liver Cirrhosis | 1 | 2017 | 1864 | 0.070 |
Why?
|
| Hepatitis C | 1 | 2017 | 1582 | 0.070 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2014 | 1872 | 0.070 |
Why?
|
| Molecular Chaperones | 1 | 2010 | 742 | 0.070 |
Why?
|
| Metabolomics | 1 | 2013 | 1467 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2014 | 4379 | 0.060 |
Why?
|
| Kynurenine | 2 | 2015 | 137 | 0.060 |
Why?
|
| Cells, Cultured | 1 | 2020 | 19223 | 0.060 |
Why?
|
| Male | 12 | 2020 | 349538 | 0.060 |
Why?
|
| DNA Methylation | 1 | 2018 | 4282 | 0.060 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 3038 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2018 | 13029 | 0.060 |
Why?
|
| Imidazoles | 1 | 2009 | 1205 | 0.050 |
Why?
|
| Models, Biological | 2 | 2017 | 9581 | 0.050 |
Why?
|
| Humans | 17 | 2020 | 742088 | 0.050 |
Why?
|
| Liver | 1 | 2018 | 7470 | 0.050 |
Why?
|
| RNA Interference | 1 | 2011 | 2890 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 4147 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 12071 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2018 | 11470 | 0.050 |
Why?
|
| Methylcellulose | 1 | 2020 | 37 | 0.050 |
Why?
|
| Cell Line | 1 | 2014 | 15994 | 0.050 |
Why?
|
| Mice, Inbred CFTR | 1 | 2018 | 19 | 0.040 |
Why?
|
| Immune Tolerance | 2 | 2020 | 2257 | 0.040 |
Why?
|
| Mucociliary Clearance | 1 | 2018 | 67 | 0.040 |
Why?
|
| Drug Compounding | 1 | 2020 | 242 | 0.040 |
Why?
|
| Ceramides | 1 | 2020 | 198 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2022 | 992 | 0.040 |
Why?
|
| Interleukin-5 | 1 | 2018 | 273 | 0.040 |
Why?
|
| Immunomodulation | 1 | 2020 | 540 | 0.040 |
Why?
|
| Female | 9 | 2020 | 379592 | 0.040 |
Why?
|
| HIV-1 | 1 | 2014 | 6934 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2020 | 712 | 0.030 |
Why?
|
| Interleukin-13 | 1 | 2018 | 389 | 0.030 |
Why?
|
| Macaca fascicularis | 1 | 2018 | 908 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2018 | 936 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2020 | 62966 | 0.030 |
Why?
|
| 1-Acylglycerophosphocholine O-Acyltransferase | 1 | 2013 | 10 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2020 | 1459 | 0.030 |
Why?
|
| Dendritic Cells | 2 | 2015 | 2723 | 0.030 |
Why?
|
| Lysophosphatidylcholines | 1 | 2013 | 81 | 0.030 |
Why?
|
| Bronchial Provocation Tests | 1 | 2013 | 227 | 0.030 |
Why?
|
| Lymphocyte Activation | 2 | 2014 | 5519 | 0.030 |
Why?
|
| Fatty Acid Desaturases | 1 | 2013 | 102 | 0.030 |
Why?
|
| Cohort Studies | 4 | 2018 | 40450 | 0.030 |
Why?
|
| Cell Movement | 2 | 2018 | 5212 | 0.030 |
Why?
|
| Arachidonate 15-Lipoxygenase | 1 | 2013 | 85 | 0.030 |
Why?
|
| Cell Extracts | 1 | 2013 | 138 | 0.030 |
Why?
|
| Blood Cell Count | 1 | 2013 | 402 | 0.030 |
Why?
|
| HL-60 Cells | 1 | 2013 | 365 | 0.030 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2014 | 425 | 0.030 |
Why?
|
| Enzyme Assays | 1 | 2013 | 111 | 0.030 |
Why?
|
| Canada | 1 | 2017 | 2061 | 0.030 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2018 | 1210 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2018 | 14720 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 2013 | 5975 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 12958 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2010 | 58 | 0.020 |
Why?
|
| Chaperonins | 1 | 2010 | 62 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2018 | 2500 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2018 | 2128 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2010 | 438 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2014 | 2557 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2010 | 473 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2010 | 689 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2014 | 1835 | 0.020 |
Why?
|
| Young Adult | 4 | 2014 | 56350 | 0.020 |
Why?
|
| Plasmids | 1 | 2013 | 2305 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2009 | 766 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2018 | 8436 | 0.020 |
Why?
|
| Middle Aged | 6 | 2017 | 213127 | 0.020 |
Why?
|
| Adult | 6 | 2017 | 213712 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2010 | 822 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2018 | 13814 | 0.020 |
Why?
|
| Viral Load | 1 | 2014 | 3292 | 0.020 |
Why?
|
| Anti-Retroviral Agents | 1 | 2015 | 1712 | 0.020 |
Why?
|
| Transfection | 1 | 2013 | 5892 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 2088 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2010 | 3127 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2013 | 3199 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 3766 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 4751 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 16665 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2014 | 8297 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2010 | 2968 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2014 | 4438 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2010 | 2938 | 0.010 |
Why?
|
| Incidence | 1 | 2018 | 20928 | 0.010 |
Why?
|
| Acute Disease | 1 | 2011 | 7141 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 2009 | 2133 | 0.010 |
Why?
|
| Cell Survival | 1 | 2010 | 5872 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 13921 | 0.010 |
Why?
|
| Anti-HIV Agents | 1 | 2014 | 4250 | 0.010 |
Why?
|
| Adolescent | 2 | 2018 | 85649 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 9735 | 0.010 |
Why?
|
| Algorithms | 1 | 2018 | 13853 | 0.010 |
Why?
|
| Aged | 3 | 2015 | 162944 | 0.010 |
Why?
|
| Prognosis | 1 | 2017 | 29010 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2017 | 53187 | 0.010 |
Why?
|
| Time Factors | 1 | 2013 | 40054 | 0.010 |
Why?
|
| Inflammation | 1 | 2011 | 10578 | 0.010 |
Why?
|
| Child | 1 | 2018 | 77478 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2018 | 77098 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 57683 | 0.010 |
Why?
|
| Mutation | 1 | 2010 | 29717 | 0.000 |
Why?
|